MedPath

Reliability and Validity of Mini-Balance Evaluation System Test (Mini-BESTest) in Type 2 Diabetic Patients with Peripheral Neuropathy

Completed
Conditions
Participants with Type 2 Diabetic Peripheral Neuropathy
Type 2 diabetes, diabetic peripheral neuropathy
Registration Number
TCTR20210130001
Lead Sponsor
Back, Neck and Other Joint Pain and Human Performance
Brief Summary

There is good inter and intra-rater reliability of Mini-BESTest found and good to excellent correlation was found between Mini-BESTest and BESTest.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
44
Inclusion Criteria

1. Patients aged between 40 to 70 years and both sexes, 2. Diagnosis as type 2 diabetes with well-controlled blood
glucose based on follow up three times of medical
assessments according to medical records, 3. Screened with Michigan Neuropathy Screening Instrument
(MNSI) and have a MNSI score greater than or equal 2.5 out of 10 by the researcher, 4. Diabetic duration of more than 5 years according to the medical record, 5. Able to understand the instructions by mini-mental state examination (MMSE)

Exclusion Criteria

1. Diagnosis as peripheral venous insufficiency or cardiac or renal
or hepatic insufficiency or uncontrolled hypertension or
myopathic by medical record, 2. Diagnosis as central nervous system dysfunction such as stroke and Parkinson disease and cerebral ataxia by medical record, 3. Foot ulcers by physical examination, 4. Fracture of the lower limbs within the 6 months before the study by physical examination, 5. Partial or complete blindness by physical examination, 6. Severe auditory problems by physical examination

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BESTest At day 1 Balance score
Secondary Outcome Measures
NameTimeMethod
Mini-BESTest At day 1 and at Day 7 Balance score
© Copyright 2025. All Rights Reserved by MedPath